In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US NIH to back the unconventional

This article was originally published in Scrip

Executive Summary

The US National Institutes of Healthare providing $42.2 million for 38 research projects that it considers to be "exceptionally innovative", and represent unconventional approaches. The grants are the first to be made under the EUREKA (Exceptional, Unconventional, Research Enabling Knowledge Acceleration) programme and include the reprogramming of adult cells (fibroblasts) to resemble embryonic stem cells and an RNA-based strategy to get substances into the brain without an injection. The first is being conducted by Dr Tanja Dominko at Worcester Polytechnic Institute, Massachusetts, and the second by Dr Beverly Davidson of the University of Iowa, Iowa City.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts